Core LaboratoriesCLB
CLB
About: Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Employees: 3,500
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0.34% more ownership
Funds ownership: 108.22% [Q4 2024] → 108.56% (+0.34%) [Q1 2025]
7% less funds holding
Funds holding: 208 [Q4 2024] → 193 (-15) [Q1 2025]
13% less capital invested
Capital invested by funds: $880M [Q4 2024] → $762M (-$118M) [Q1 2025]
28% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 76
32% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 34
34% less call options, than puts
Call options by funds: $321K | Put options by funds: $487K
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$12
8%
upside
Avg. target
$12.50
12%
upside
High target
$13
17%
upside
2 analyst ratings
0 positive
0%
2 neutral
100%
0 negative
0%
Stifel Stephen Gengaro | 8%upside $12 | Hold Maintained | 16 Jul 2025 |
Citigroup Scott Gruber | 17%upside $13 | Neutral Maintained | 13 May 2025 |
Financial journalist opinion
Based on 8 articles about CLB published over the past 30 days
Positive
The Motley Fool
2 days ago
Core Labs Posts Flat Revenue in Q2
Core Laboratories (CLB 2.98%), a specialist in reservoir optimization and production enhancement services for the oil and gas industry, reported its second quarter 2025 earnings on July 23, 2025. GAAP revenue of $130.2 million for Q2 2025 outpaced analyst expectations of $129.1 million, and adjusted EPS of $0.19 matched consensus estimates.
Positive
Zacks Investment Research
5 days ago
Core Laboratories Q2 Earnings Beat Estimates, Expenses Increase Y/Y
CLB's second-quarter earnings beat estimates. However, it declined year over year due to the underperformance of the Reservoir Description segment.
Neutral
Seeking Alpha
6 days ago
Core Laboratories Inc. (CLB) Q2 2025 Earnings Call Transcript
Core Laboratories Inc. (NYSE:CLB ) Q2 2025 Earnings Conference Call July 24, 2025 8:30 AM ET Company Participants Christopher Scott Hill - Senior VP & CFO Gwendolyn Y. Gresham - Senior Vice President of Corporate Development & Investor Relations Lawrence V.
Positive
Zacks Investment Research
1 week ago
Core Laboratories (CLB) Beats Q2 Earnings and Revenue Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.22 per share a year ago.
Neutral
PRNewsWire
1 week ago
CORE LAB REPORTS SECOND QUARTER 2025 RESULTS
REVENUE OF $130.2 MILLION, UP 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $15.3 MILLION; EX-ITEMS, $14.5 MILLION, UP OVER 23% SEQUENTIALLY AND DOWN 11% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF 11%, EXPANDED 160 BASIS POINTS SEQUENTIALLY, WITH INCREMENTAL MARGINS, EX-ITEMS, OF 41% GAAP EPS OF $0.22; EX-ITEMS, $0.19, UP 33% SEQUENTIALLY, AND DOWN 14% YEAR-OVER-YEAR COMPANY REPURCHASED 237,632 SHARES OF COMMON STOCK, A VALUE OF $2.7 MILLION FREE CASH FLOW OF $10.4 MILLION, UP OVER 160% SEQUENTIALLY NET DEBT REDUCED BY $9.1 MILLION; DEBT LEVERAGE RATIO IMPROVED TO 1.27 COMPANY ANNOUNCES Q2 2025 QUARTERLY DIVIDEND HOUSTON , July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of $130,200,000. Core's operating income was $15,300,000, with earnings per diluted share ("EPS") of $0.22, all in accordance with U.S. generally accepted accounting principles ("GAAP").
Neutral
Zacks Investment Research
1 week ago
Watch These 4 Energy Stocks for Q2 Earnings: Beat or Miss?
Here's a preview of what to expect from energy stocks EQNR, CLB, OII and PTEN ahead of their quarterly earnings reports, set to be released tomorrow.
Negative
Zacks Investment Research
1 week ago
Core Laboratories to Post Q2 Earnings: Key Metrics to Watch
CLB's second-quarter revenues are likely to have declined from the year-ago period's level due to weak segment revenues.
Negative
Zacks Investment Research
1 month ago
Core Lab Stock Plunges 22% in Six Months: Time to Hold or Sell?
CLB struggles with declining revenues, geopolitical risks, margin compression and weak U.S. demand, creating uncertainty around growth and profitability prospects.
Positive
Seeking Alpha
1 month ago
Core Laboratories: Better Without Its Non-Core?
Core Laboratories trades near five-year lows but suffers from limited investor interest and unclear financial segment breakdowns, despite global diversification and energy transition exposure. Reservoir Description is the standout segment, offering recurring, high-margin services with long-term demand, especially as energy transition projects like CCS gain traction. Production Enhancement faces high competition and low margins, and the company's lack of transparency and communication limits investor confidence and potential re-rating.
Neutral
PRNewsWire
1 month ago
CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON , June 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m.
Charts implemented using Lightweight Charts™